Cargando…

Independent and Joint Association of Statin Therapy with Adverse Outcomes in Heart Failure Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy

BACKGROUND: The joint association of atrial fibrillation (AF) and statin therapy with adverse outcomes in heart failure (HF) patients with cardiac resynchronization therapy (CRT) has not been fully investigated so far. The purpose of this study was to explore the independent and joint association of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yu, Ding, Ligang, Deng, Yu, Huang, Hao, Cheng, Sijing, Cai, Chi, Gu, Min, Chen, Xuhua, Ning, Xiaohui, Niu, Hongxia, Hua, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749032/ https://www.ncbi.nlm.nih.gov/pubmed/36532652 http://dx.doi.org/10.2147/JIR.S390127

Ejemplares similares

Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator
por: Chen, Jie, et al.
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
por: Gasparini, Maurizio, et al.
Publicado: (2009)

Length of Hospitalization-Related Differences and Associated Long-Term Prognosis of Patients with Cardiac Resynchronization Therapy: A Propensity Score-Matched Cohort
por: Yu, Yu, et al.
Publicado: (2022)

A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy
por: Cai, Minsi, et al.
Publicado: (2020)

Effectiveness of adding a defibrillator with cardiac resynchronization therapy in heart failure according to the modified Model for End-stage Liver Disease-Albumin score
por: Cheng, Sijing, et al.
Publicado: (2023)

Clinical Implications of Device-Detected Atrial Fibrillation in Cardiac Resynchronization Therapy
por: Yoon, Minjae, et al.
Publicado: (2023)

The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score
por: Akşit, Ercan, et al.
Publicado: (2023)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy
por: Bianchi, Stefano, et al.
Publicado: (2022)

Independent and joint association of N-terminal pro-B-type natriuretic peptide and left ventricular mass index with heart failure risk in elderly diabetic patients with right ventricular pacing
por: Yu, Yu, et al.
Publicado: (2022)

Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response
por: Hwang, Jin Kyung, et al.
Publicado: (2019)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation
por: Choi, Kang‐Ho, et al.
Publicado: (2019)

Sex differences in the nonlinear association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population
por: Yu, Yu, et al.
Publicado: (2023)

Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy
por: Sticherling, Christian, et al.
Publicado: (2018)

Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy
por: Mittal, Suneet, et al.
Publicado: (2017)

Cardiac resynchronization therapy in the presence of total atrioventricular block reduces long‐lasting atrial fibrillation episodes
por: Kugler, Lara, et al.
Publicado: (2022)

Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
por: Nomani, Homa, et al.
Publicado: (2021)

Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy
por: Jacobsson, Jonatan, et al.
Publicado: (2019)

Joint association of sedentary behavior and vitamin D status with mortality among cancer survivors
por: Yu, Yu, et al.
Publicado: (2023)

Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
por: Nedios, Sotirios, et al.
Publicado: (2020)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Early Smartphone App-Based Remote Diagnosis of Silent Atrial Fibrillation and Ventricular Fibrillation in a Patient with Cardiac Resynchronization Therapy Defibrillator
por: Kowal, Dagmar, et al.
Publicado: (2023)

Outcomes of Atrioventricular Node Ablation and Pacing in Patients with Heart Failure and Atrial Fibrillation: From Cardiac Resynchronization Therapy to His Bundle Pacing
por: Koniari, Ioanna, et al.
Publicado: (2023)

An unusual failure of cardiac resynchronization therapy
por: Higuchi, Satoshi, et al.
Publicado: (2022)

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)

Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population
por: Yu, Yu, et al.
Publicado: (2022)

Statin therapy in the primary prevention of early atrial fibrillation after coronary artery bypass grafting
por: Bockeria, O.L., et al.
Publicado: (2016)

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score
por: Yang, Shengwen, et al.
Publicado: (2020)

Association of Kidney Function With Risk of Adverse Effects of Therapies for Atrial Fibrillation
por: Bansal, Nisha, et al.
Publicado: (2022)

Predictive Value of Left Atrial Remodeling for Response to Cardiac Resynchronization Therapy
por: Bouwmeester, Sjoerd, et al.
Publicado: (2022)

Cardiac Resynchronization Therapy and Left Atrial Remodeling: A Novel Insight?
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Impact of Estimated Left Atrial Pressure on Cardiac Resynchronization Therapy Outcome
por: Beela, Ahmed S., et al.
Publicado: (2023)

Anemia as an Independent Predictor of Adverse Cardiac Outcomes in Patients with Atrial Fibrillation
por: Lee, Wen-Hsien, et al.
Publicado: (2015)

The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis
por: Waranugraha, Yoga, et al.
Publicado: (2021)

Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy
por: Zhang, Nixiao, et al.
Publicado: (2022)

Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2012)

Statin Therapy Decreased the Recurrence Frequency of Atrial Fibrillation after Electrical Cardioversion: A Meta-Analysis
por: Yan, Peng, et al.
Publicado: (2014)

Pleiotropic effects of statins in atrial fibrillation patients: the evidence
por: Hadi, Hadi AR, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2t8mj6042fqi0lrtkj9952pl4v